Form 4: Cardlytics Director Scott A. Hill Reports Stock Transactions
SEC Form 4 Filing
Director Scott A. Hill reports the vesting and conversion of restricted stock units into Cardlytics common stock.
Summary
- On September 5, 2024, Scott A. Hill, a director of Cardlytics, Inc. (CDLX), reported a transaction involving restricted stock units (RSUs).
- Hill converted 6,748 RSUs into 6,748 shares of Cardlytics common stock.
- The RSUs vested in full on the one-year anniversary of the grant date.
- Following the transaction, Hill directly owns 46,748 shares of Cardlytics common stock.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider stock activity.
Key Dates
| Date | Description |
|---|---|
| 09/05/2024 | Date of transaction: Conversion of restricted stock units to common stock. |
| 09/09/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.